| 1.Case definition explicit and appropriate? |
|
|
| 2.How is maternal vitamin D measured? |
|
|
| 3. Participants grouped according to Vitamin D status? |
|
|
| 4. Measurements of outcomes reliably ascertained? |
|
|
| 5. Measurement of later outcomes objective? |
|
|
| 6. Control selection appropriate? |
|
|
| 7. Measures of vitamin D intake/25(OH)- Vitamin D level, outcomes rounded? |
|
|
| 8. Setting and population appropriate? |
|
|
| 9. Outcome assessment blind to Vitamin D status? |
|
|
| 10. Analysis rigorous and appropriate? |
|
|
11. Response rates for:
cases
controls
(a separate score for each should be given) |
|
|
| 12. Info on representativeness and non-participants |
|
|
13. Sample sizes for:
cases
controls
(a separate score for each should be given) |
|
|
| 14. Adequate consideration for important confounding factors? (eg season, sunlight exposure, calcium intake, maternal compliance, infant feeding) |
|
|
|
Overall quality rating (sum of scores): |
|
|
|
f. Study results – free text, to consider cohort details, associations found, any additional quality comments |
|